Senti Biosciences, Inc. (SNTI) Financials

SNTI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 33.1 million 36.5 million
March 31, 2026 38.2 million 35.7 million
Dec. 31, 2025 51.2 million 45.6 million
Sept. 30, 2025 52.7 million 44.6 million

SNTI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.2 million 1.0 million
March 31, 2026 -7.5 million 1.3 million
Dec. 31, 2025 -6.9 million 1.4 million
Sept. 30, 2025 -9.4 million 1.6 million

SNTI Net Income

No data available :(

SNTI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 6.5 million - -
March 31, 2026 8.9 million - 19.1 million
Dec. 31, 2025 16.4 million - 28.9 million
Sept. 30, 2025 12.2 million - 30.1 million

SNTI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 31.1 million
March 31, 2026 31.0 million
Dec. 31, 2025 22.5 million
Sept. 30, 2025 26.2 million

SNTI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 7.8 million 6.7 million -
March 31, 2026 - 5.3 million 5.8 million -
Dec. 31, 2025 - 7.8 million 5.8 million -
Sept. 30, 2025 - 10.5 million 5.8 million -

SNTI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 16000 -
Dec. 31, 2025 22000 893000
Sept. 30, 2025 - 904000

SNTI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

SNTI

Price: $0.39

52 week price:
0.33
2.88

Earnings Per Share: -1.69 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 13.4 million

Links: